MRI Interventions PIPE
$11,000,000
First Analysis acted as the co-lead placement agent in an $11 million private placement for MRI Interventions, a commercial-stage medical device company enabling a range of minimally invasive procedures in the brain. As part of this investment, the company issued common stock and warrants to purchase common stock.
About MRI Interventions:
MRI Interventions (MRIC) is a leading platform neurosurgery company. The company’s mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Applications of the company’s current product portfolio include deep-brain stimulation, laser ablation, biopsy, neuro-aspiration, and delivery of drugs, biologics and gene therapy to the brain. MRI Interventions changed its corporate name to ClearPoint Neuro (CLPT) in February 2020.